deltatrials
Completed PHASE3 INTERVENTIONAL 1-arm NCT02766777

Evaluation of the Safety of Lubiprostone in Pediatric Participants Aged ≥ 6 Years to < 18 Years With Functional Constipation

A Multicenter, 6-month, Open-label Safety Study of Lubiprostone in Pediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation

Sponsor: Sucampo AG

Interventions Lubiprostone
Updated 10 times since 2017 Last updated: May 4, 2020 Started: Apr 12, 2016 Primary completion: Nov 4, 2016 Completion: Nov 4, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Constipation - Functional and is currently completed. Sucampo AG leads this study, which shows 10 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Apr 2018 · 14 months · monthly snapshotCompleted~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2020 · 19 months · monthly snapshotCompleted~Jan 2020 – ~Jun 2020 · 5 months · monthly snapshotCompleted~Jun 2020 – ~Jan 2021 · 7 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

10 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  5. Jun 2020 — Jan 2021 [monthly]

    Completed PHASE3

Show 5 earlier versions
  1. Jan 2020 — Jun 2020 [monthly]

    Completed PHASE3

  2. Jun 2018 — Jan 2020 [monthly]

    Completed PHASE3

  3. Apr 2018 — Jun 2018 [monthly]

    Completed PHASE3

  4. Feb 2017 — Apr 2018 [monthly]

    Completed PHASE3

  5. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE3

    First recorded

Apr 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Sucampo AG
  • Sucampo Pharma Americas, LLC
Data source: Mallinckrodt

For direct contact, visit the study record on ClinicalTrials.gov .